Gene · 5892
Papers2,681
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,681
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genomic Signature for Initial Brain Metastasis Velocity (iBMV) in Non-Small-Cell Lung Cancer Patients: The Elusive Biomarker to Predict the Development of Brain Metastases? | Cancers (Basel) | 2025 | 40149325 | PubTator, text mining | PubMed |
| Extracellular vesicles in lung donor plasma: Potential indicators of donor organ quality. | J Thorac Cardiovasc Surg | 2025 | 40118141 | PubTator, text mining | PubMed |
| Pathogenic germline variants in cancer predisposition genes in patients with multiple primary cancers in an Asian population and the role of extended panel genetic testing. | ESMO Open | 2025 | 40068381 | PubTator, text mining | PubMed |
| Reduced reproductive potential in young healthy women with hereditary breast and/or ovarian cancer syndrome. | Commun Med (Lond) | 2025 | 40057639 | PubTator, text mining | PubMed |
| Pathogenic germline variants in Chinese pancreatic adenocarcinoma patients. | Nat Commun | 2025 | 40044664 | PubTator, text mining | PubMed |
| Inner membrane components of the plasmid pKM101 type IV secretion system TraE and TraD are DNA-binding proteins. | Sci Rep | 2025 | 40032854 | PubTator, text mining | PubMed |
| Prevalence of Constitutional Pathogenic Variant in a Cohort of 348 Patients With Multiple Primary Cancer Addressed in Oncogenetic Consultation. | Mol Genet Genomic Med | 2025 | 40022545 | PubTator, text mining | PubMed |
| Considerations for hereditary breast and ovarian cancer syndrome molecular diagnosis: experience from the clinical practice. | Breast Cancer Res Treat | 2025 | 39992612 | PubTator, text mining | PubMed |
| Mutations in homologous recombination repair genes in patients with metastatic endometrial cancer: association with clinical characteristics and prognosis. | J Gynecol Oncol | 2025 | 39950607 | PubTator, text mining | PubMed |
| Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer. | Eur J Hum Genet | 2025 | 39939714 | PubTator, text mining | PubMed |
| Morphologic Correlations With Homologous Recombination Deficiency in High-grade Serous Carcinomas. | Int J Gynecol Pathol | 2025 | 39868725 | PubTator, text mining | PubMed |
| PRMT5-regulated splicing of DNA repair genes drives chemoresistance in breast cancer stem cells. | Oncogene | 2025 | 39695328 | PubTator, text mining | PubMed |
| Pathogenic Variants in Cancer Susceptibility Genes Predispose to Ductal Carcinoma In Situ of the Breast. | Clin Cancer Res | 2025 | 39513960 | PubTator, text mining | PubMed |
| Germline variants of homology-directed repair or mismatch repair genes in cervical cancer. | Int J Cancer | 2025 | 39440754 | PubTator, text mining | PubMed |
| Germline genetic mutations in a multi-center cohort of 248 phyllodes tumors. | Breast Cancer Res Treat | 2025 | 39269552 | PubTator, text mining | PubMed |
| Clinical Impact of Constitutional Genomic Testing on Current Breast Cancer Care. | Clin Oncol (R Coll Radiol) | 2025 | 39242249 | PubTator, text mining | PubMed |
| The pathologic and clinical outcomes of risk-reducing salpingo-oophorectomy in asymptomatic carriers of homologous recombination repair gene mutation. | J Gynecol Oncol | 2025 | 39028150 | PubTator, text mining | PubMed |
| A portrait of germline pathogenic variants in high and moderate penetrance breast cancer genes in Brazil. | Front Oncol | 2024 | 39741970 | PubTator, text mining | PubMed |
| Patterns of genomic instability in > 2000 patients with ovarian cancer across six clinical trials evaluating olaparib. | Genome Med | 2024 | 39695768 | PubTator, text mining | PubMed |
| Comprehensive Clinical Genetics, Molecular and Pathological Evaluation Efficiently Assist Diagnostics and Therapy Selection in Breast Cancer Patients with Hereditary Genetic Background. | Int J Mol Sci | 2024 | 39684258 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5892/papers?page=7